BillionToOne Job Trends
7
Active Jobs (Last 14 Days)
2
Fresh Jobs (Last 3 Days)
86%
Jobs with Salary Data
Recent Job Posting Activity (30 Days)
Job Category Distribution
Current BillionToOne Jobs, Salary Data, and Stats
In the last two weeks, BillionToOne has posted 7 positions. None of those roles offer remote or hybrid work. We've been tracking BillionToOne since March 17, 2025.
Career Tracks Currently Hiring
Currently Hiring Office Locations
Central Missouri Wisconsin Houston, TX Charlotte East, NC Grand Rapids North, MI and 49 moreCurrent BillionToOne Jobs
Last updated: May 21, 2025
Showing 7 active jobs. Active jobs were posted in the last 14 days. Fresh jobs were posted within the last 3 days. Click a row for more details.
Showing filtered results for ""
| Role | |
|---|---|
Account ExecutiveApply →Fresh
May 20 $182,346 - $245,856; $124,646 - $150,656
WashingtonBillionToOne is a next-generation molecular diagnostics company dedicated to developing powerful and accurate diagnostic tests that are accessible to all. Our innovative QCT molecular counting technology significantly enhances the resolution of disease detection using cell-free DNA by over a thousandfold. This groundbreaking technology is integral to our product offerings, including one of our flagship products, Unity Complete™ , the only non-invasive prenatal screen capable of assessing fetal risk for both common recessive conditions and aneuploidies from a single maternal blood sample. Leveraging the same molecular counting technology, we've expanded our impact into oncology in 2023 with a pioneering liquid biopsy... | |
Oncology Account ExecutiveFresh
Med Practice
May 19 $239,608 - $308,964; $155,858 - $181,464 Spokane, WA Apply →Oncology Account ExecutiveApply →Fresh
Med Practice
May 19 $239,608 - $308,964; $155,858 - $181,464
Spokane, WABillionToOne is a next-generation molecular diagnostics company dedicated to developing powerful and accurate diagnostic tests that are accessible to all. Our innovative QCT molecular counting technology significantly enhances the resolution of disease detection using cell-free DNA by over a thousandfold. This groundbreaking technology is integral to our product offerings, including one of our flagship products, Unity Complete™ , the only non-invasive prenatal screen capable of assessing fetal risk for both common recessive conditions and aneuploidies from a single maternal blood sample. Leveraging the same molecular counting technology, we've expanded our impact into oncology in 2023 with a pioneering liquid biopsy... | |
Senior Customer Service RepresentativeApply →May 15 $78,030 - $83,232
Union City, CABillionToOne is a next-generation molecular diagnostics company dedicated to developing powerful and accurate diagnostic tests that are accessible to all. Our innovative QCT molecular counting technology significantly enhances the resolution of disease detection using cell-free DNA by over a thousandfold. This groundbreaking technology is integral to our product offerings, including one of our flagship products, Unity Complete™ , the only non-invasive prenatal screen capable of assessing fetal risk for both common recessive conditions and aneuploidies from a single maternal blood sample. Leveraging the same molecular counting technology, we've expanded our impact into oncology in 2023 with a pioneering liquid biopsy... | |
Account ExecutiveApply →May 15 $239,608 - $308,964; $155,858 - $171,464
Springfield South, IllinoisBillionToOne is a next-generation molecular diagnostics company dedicated to developing powerful and accurate diagnostic tests that are accessible to all. Our innovative QCT molecular counting technology significantly enhances the resolution of disease detection using cell-free DNA by over a thousandfold. This groundbreaking technology is integral to our product offerings, including one of our flagship products, Unity Complete™ , the only non-invasive prenatal screen capable of assessing fetal risk for both common recessive conditions and aneuploidies from a single maternal blood sample. Leveraging the same molecular counting technology, we've expanded our impact into oncology in 2023 with a pioneering liquid biopsy... | |
Oncology SpecialistMed Practice
May 15 $239,608 - $308,964; $155,858 - $171,464 San Antonio-Rio Grande Valley, South Texas Apply →Oncology SpecialistApply →Med Practice
May 15 $239,608 - $308,964; $155,858 - $171,464
San Antonio-Rio Grande Valley, South TexasBillionToOne is a next-generation molecular diagnostics company dedicated to developing powerful and accurate diagnostic tests that are accessible to all. Our innovative QCT molecular counting technology significantly enhances the resolution of disease detection using cell-free DNA by over a thousandfold. This groundbreaking technology is integral to our product offerings, including one of our flagship products, Unity Complete™ , the only non-invasive prenatal screen capable of assessing fetal risk for both common recessive conditions and aneuploidies from a single maternal blood sample. Leveraging the same molecular counting technology, we've expanded our impact into oncology in 2023 with a pioneering liquid biopsy... | |
Customer Service RepresentativeApply →May 14 Salary N/A
Union City, CABillionToOne is a next-generation molecular diagnostics company dedicated to developing powerful and accurate diagnostic tests that are accessible to all. Our innovative QCT molecular counting technology significantly enhances the resolution of disease detection using cell-free DNA by over a thousandfold. This groundbreaking technology is integral to our product offerings, including one of our flagship products, Unity Complete™ , the only non-invasive prenatal screen capable of assessing fetal risk for both common recessive conditions and aneuploidies from a single maternal blood sample. Leveraging the same molecular counting technology, we've expanded our impact into oncology in 2023 with a pioneering liquid biopsy... | |
Oncology SpecialistMed Practice
May 11 $239,608 - $308,964; $155,858 - $171,464 Cleveland, Ohio Apply →Oncology SpecialistApply →Med Practice
May 11 $239,608 - $308,964; $155,858 - $171,464
Cleveland, OhioBillionToOne is a next-generation molecular diagnostics company dedicated to developing powerful and accurate diagnostic tests that are accessible to all. Our innovative QCT molecular counting technology significantly enhances the resolution of disease detection using cell-free DNA by over a thousandfold. This groundbreaking technology is integral to our product offerings, including one of our flagship products, Unity Complete™ , the only non-invasive prenatal screen capable of assessing fetal risk for both common recessive conditions and aneuploidies from a single maternal blood sample. Leveraging the same molecular counting technology, we've expanded our impact into oncology in 2023 with a pioneering liquid biopsy... | |